The original content of Democracy Now! Headlines appears under the Creative
Commons BY-NC-ND 3.0 License (United States). For more, including their other
shows and media, visit www.democracynow.org.
March 15, 2023

Novo Nordisk Is Second Major Drug Co. to Cut Price of Insulin After Intense Public Pressure
-------------------------------------------------------------------------------------------

Novo Nordisk announced it is lowering the cost of insulin by up to 70%.
This follows a similar move by drug competitor Eli Lilly earlier this
month and comes after years of pressure from activists, lawmakers and
people with diabetes. It also puts pressure on Sanofi, the other major
insulin manufacturer in the U.S., to follow suit. Last week,
Congressmember Cori Bush and Senator Bernie Sanders introduced the
Insulin for All Act to cap insulin prices at $20 per vial.


.